Literature DB >> 8706338

Structural polymorphisms of complement receptor 1 (CR1) in systemic lupus erythematosus (SLE) patients and normal controls of three ethnic groups.

J M Moulds1, J D Reveille, F C Arnett.   

Abstract

CR1 exhibits a molecular weight polymorphism and variability in the number of C3b-binding sites. Because this may affect immune complex clearance, we used erythrocytes to investigate the CR1 size polymorphism in SLE patients from three ethnic groups. The CR1-C allele was found more frequently in African-Americans, but the frequency did not differ between controls (10%, n = 63) and SLE patients (9%, n = 79). A 160-kD band similar to CR1-C was noted in a number of patients and was shown to be a proteolytic cleavage fragment. The study shows that the smallest form of CR1, i.e. CR1-C, is not a genetic risk factor for SLE and that the frequencies of the CR1 structural alleles do not differ from race-matched healthy controls.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706338      PMCID: PMC2200506          DOI: 10.1046/j.1365-2249.1996.d01-748.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

Review 1.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

2.  Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis.

Authors:  Swapan K Nath; John B Harley; Young Ho Lee
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

3.  Complement receptor 1 and the molecular pathogenesis of malaria.

Authors:  Monika Gandhi
Journal:  Indian J Hum Genet       Date:  2007-05

Review 4.  Role of RUNX in autoimmune diseases linking rheumatoid arthritis, psoriasis and lupus.

Authors:  Marta E Alarcón-Riquelme
Journal:  Arthritis Res Ther       Date:  2004-06-21       Impact factor: 5.156

5.  Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer's disease.

Authors:  Ezgi Kucukkilic; Keeley Brookes; Imelda Barber; Tamar Guetta-Baranes; Kevin Morgan; Edward J Hollox
Journal:  Hum Genet       Date:  2018-04-19       Impact factor: 4.132

6.  A novel mouse model expressing human forms for complement receptors CR1 and CR2.

Authors:  Harriet M Jackson; Kate E Foley; Rita O'Rourke; Timothy M Stearns; Dina Fathalla; B Paul Morgan; Gareth R Howell
Journal:  BMC Genet       Date:  2020-09-09       Impact factor: 2.797

7.  Regulatory Architecture of the RCA Gene Cluster Captures an Intragenic TAD Boundary, CTCF-Mediated Chromatin Looping and a Long-Range Intergenic Enhancer.

Authors:  Jessica Cheng; Joshua S Clayton; Rafael D Acemel; Ye Zheng; Rhonda L Taylor; Sündüz Keleş; Martin Franke; Susan A Boackle; John B Harley; Elizabeth Quail; José Luis Gómez-Skarmeta; Daniela Ulgiati
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

8.  Circulating Immune Complex Levels are Associated with Disease Severity and Seasonality in Children with Malaria from Mali.

Authors:  Bolaji N Thomas; Dapa A Diallo; Ghislain T Noumsi; Joann M Moulds
Journal:  Biomark Insights       Date:  2012-07-03

Review 9.  Complement Receptor 1: disease associations and therapeutic implications.

Authors:  Rohan Khera; Nibhriti Das
Journal:  Mol Immunol       Date:  2008-11-11       Impact factor: 4.407

Review 10.  Genetic Insights into the Impact of Complement in Alzheimer's Disease.

Authors:  Megan Torvell; Sarah M Carpanini; Nikoleta Daskoulidou; Robert A J Byrne; Rebecca Sims; B Paul Morgan
Journal:  Genes (Basel)       Date:  2021-12-15       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.